As per the bulk deal data on the NSE, BNP Paribas Arbitrage sold 5,14,463 equity shares or 1.43% stake of Solara Active Pharma Science at Rs 1,463 per share on Monday, 19 April 2021.
On the same day, the Scottish Oriental Smaller Companies Trust Plc bought 1,99,259 equity shares or 0.55% stake of Solara Active Pharma Science at Rs 1,462.25 per share via bulk deal on NSE.
As of 31 March 2021, BNP Paribas Arbitrage held 3.50% stake in Solara Active Pharma Science.
Shares of Solara Active Pharma fell 0.03% to Rs 1,461.30 on BSE. The scrip hit a high of Rs 1,520 and a low of Rs 1,455 so far.
On a consolidated basis, the company posted a 59.2% jump in net profit to Rs 65.78 crore on a 24.2% rise in net sales to Rs 426.69 crore in Q3 FY21 over Q3 FY20.
Solara Active Pharma Sciences offers a basket of diversified, high-value commercial APIs and contract manufacturing services in over 75 countries.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU